{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:19:49Z","timestamp":1789903189007,"version":"4.0.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2015,11,1]]},"DOI":"10.1093\/cid\/civ498","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T20:10:02Z","timestamp":1437250202000},"page":"1446-1452","source":"Crossref","is-referenced-by-count":21,"title":["Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice"],"prefix":"10.1093","volume":"61","author":[{"given":"Matthew J.","family":"Labreche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,23]]},"reference":[{"key":"2015100908024942000_61.9.1446.1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.3.289"},{"key":"2015100908024942000_61.9.1446.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2011.02.005"},{"key":"2015100908024942000_61.9.1446.3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00047-06"},{"key":"2015100908024942000_61.9.1446.4","doi-asserted-by":"publisher","DOI":"10.1086\/510079"},{"key":"2015100908024942000_61.9.1446.5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05360-11"},{"key":"2015100908024942000_61.9.1446.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000094940.81959.14"},{"key":"2015100908024942000_61.9.1446.7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(50)90425-6"},{"key":"2015100908024942000_61.9.1446.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2006.12.012"},{"key":"2015100908024942000_61.9.1446.9","doi-asserted-by":"crossref","DOI":"10.3109\/9781420017137","volume-title":"Antimicrobial pharmacodynamics in theory and clinical practice","author":"Nightingale","year":"2007"},{"key":"2015100908024942000_61.9.1446.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.5.1073"},{"key":"2015100908024942000_61.9.1446.11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.13-22.2001"},{"key":"2015100908024942000_61.9.1446.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(00)00185-1"},{"key":"2015100908024942000_61.9.1446.13","doi-asserted-by":"publisher","DOI":"10.1086\/513766"},{"key":"2015100908024942000_61.9.1446.14","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(83)90029-9"},{"key":"2015100908024942000_61.9.1446.15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00580-11"},{"key":"2015100908024942000_61.9.1446.16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit017"},{"key":"2015100908024942000_61.9.1446.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2010.09.006"},{"key":"2015100908024942000_61.9.1446.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70036-2"},{"key":"2015100908024942000_61.9.1446.19","unstructured":"Kahlmeter G . EUCAST at CLSI. Available at: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/EUCAST_Presentations\/EUCAST_CLSI_Boston_2009.pdf . Accessed 16 January 2015."},{"key":"2015100908024942000_61.9.1446.20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir031"},{"key":"2015100908024942000_61.9.1446.21","unstructured":"Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-fifth informational supplement. CLSI document (M100-S25). Wayne, PA, 2015."},{"key":"2015100908024942000_61.9.1446.22","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. Available at: http:\/\/www.eucast.org . Accessed January 16 2015."},{"key":"2015100908024942000_61.9.1446.23","article-title":"FDA Approved Drug Products","author":"US Food and Drug Administration (FDA)"},{"key":"2015100908024942000_61.9.1446.24","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00837-11"},{"key":"2015100908024942000_61.9.1446.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079130"},{"key":"2015100908024942000_61.9.1446.26","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12090"},{"key":"2015100908024942000_61.9.1446.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt450"},{"key":"2015100908024942000_61.9.1446.28","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt136"},{"key":"2015100908024942000_61.9.1446.29","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/25.4.679"},{"key":"2015100908024942000_61.9.1446.30","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443130-00005"},{"key":"2015100908024942000_61.9.1446.31","doi-asserted-by":"publisher","DOI":"10.1086\/513203"},{"key":"2015100908024942000_61.9.1446.32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit178"},{"key":"2015100908024942000_61.9.1446.33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir078"},{"key":"2015100908024942000_61.9.1446.34","doi-asserted-by":"publisher","DOI":"10.1086\/600877"},{"key":"2015100908024942000_61.9.1446.35","doi-asserted-by":"publisher","DOI":"10.1086\/598975"},{"key":"2015100908024942000_61.9.1446.36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.42.9.2375","article-title":"In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations","volume":"42","author":"Andes","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2015100908024942000_61.9.1446.37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu568"},{"key":"2015100908024942000_61.9.1446.38","unstructured":"Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement. CLSI document (M100-S23). Wayne, PA, 2013."},{"key":"2015100908024942000_61.9.1446.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.03.022"},{"key":"2015100908024942000_61.9.1446.40","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00788-11"},{"key":"2015100908024942000_61.9.1446.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.08.024"},{"key":"2015100908024942000_61.9.1446.42","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks088"},{"key":"2015100908024942000_61.9.1446.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01265.x"},{"key":"2015100908024942000_61.9.1446.44","doi-asserted-by":"publisher","DOI":"10.1086\/500661"},{"key":"2015100908024942000_61.9.1446.45","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis916"},{"key":"2015100908024942000_61.9.1446.46","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis688"},{"key":"2015100908024942000_61.9.1446.47","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01743-10"},{"key":"2015100908024942000_61.9.1446.48","unstructured":"Ambrose PG . The Challenge: Antibiotics and unmet medical need. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Presentation\/2013\/09\/WC500150491.pdf . Accessed 16 January 2015."},{"key":"2015100908024942000_61.9.1446.49","article-title":"Rational susceptibility test interpretative criteria: Perspectives from the USCAST","author":"Ambrose"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/9\/1446\/1189121\/civ498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T07:59:45Z","timestamp":1566979185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ498"}},"subtitle":[],"editor":[{"given":"Louis D.","family":"Saravolatz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,23]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,10,9]]},"published-print":{"date-parts":[[2015,11,1]]}},"alternative-id":["10.1093\/cid\/civ498"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ498","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,23]]}}}